Companies
Deciphex closes out Series B round with additional €4m raise
Dublin-based Seroba Life Sciences has participated in the additional financing along with existing investors
Deciphex, a company that develops software to accelerate the delivery of pathology services, has secured an additional €3.9m funding to close its Series B round at €14.4 million.
The financing comes seven months after the firm announced it had raised $11.5 million from backers that includes pharma giant Novartis, contact research organisation Charles River Laboratories, and Act Venture Capital.
Dublin-based Seroba Life Sciences has participated in the additional financing along with existing investors. Jennifer McMahon, ...